Effectiveness of COVID-19 Vaccines at Preventing Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompromised Adults: An Observational Study of Real-World Data Across 10 US States from August-December 2021

BACKGROUND: Immunocompromised (IC) persons are at increased risk for severe COVID-19 outcomes and are less protected by 1-2 COVID-19 vaccine doses than are immunocompetent (non-IC) persons. We compared vaccine effectiveness (VE) against medically attended COVID-19 of 2-3 mRNA and 1-2 viral-vector va...

Descripción completa

Detalles Bibliográficos
Autores principales: Embi, Peter J., Levy, Matthew E., Patel, Palak, DeSilva, Malini B., Gaglani, Manjusha, Dascomb, Kristin, Dunne, Margaret M., Klein, Nicola P., Ong, Toan C., Grannis, Shaun J., Natarajan, Karthik, Yang, Duck-Hye, Stenehjem, Edward, Zerbo, Ousseny, McEvoy, Charlene, Rao, Suchitra, Thompson, Mark G., Konatham, Deepika, Irving, Stephanie A., Dixon, Brian E., Han, Jungmi, Schrader, Kristin E., Grisel, Nancy, Lewis, Ned, Kharbanda, Anupam B., Barron, Michelle A., Reynolds, Sue, Liao, I-Chia, Fadel, William F., Rowley, Elizabeth A., Arndorfer, Julie, Goddard, Kristin, Murthy, Kempapura, Valvi, Nimish R., Weber, Zachary A., Fireman, Bruce, Reese, Sarah E., Ball, Sarah W., Naleway, Allison L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201325/
https://www.ncbi.nlm.nih.gov/pubmed/37479609
http://dx.doi.org/10.1016/j.vaccine.2023.05.038

Ejemplares similares

Ejemplares similares